Side-by-side financials for CTKB and ILMN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CTKB | ILMN |
|---|---|---|
| Market cap | - | $25.15 B |
| US-listed rank | - | #533 |
| Revenue (latest FY) | $201.49M | $4.34B |
| Net income (latest FY) | -$66.54M | $850.00M |
| Net margin | -33.0% | 19.6% |
| P/E (trailing FY) | - | 29.6 |
| SEC filings | 432 | 3,713 |
In their latest fiscal years, Cytek Biosciences, Inc. reported $201.49M in revenue while ILLUMINA, INC. reported $4.34B.
Full pages: Cytek Biosciences, Inc. and ILLUMINA, INC., or browse the full rankings.